Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
DST j. bras. doenças sex. transm ; 32: 1-4, jan. 12, 2020.
Article in English | LILACS | ID: biblio-1123226

ABSTRACT

Introduction: The human body is colonized by trillions of microbial cells, called the microbiota. The microbiome is defined as microbial cells and their genomes. Vaginal microbiota, especially lactic acid bacteria (mainly Lactobacillus sp.), seem to play a critical role in the prevention of various urogenital diseases such as bacterial vaginosis, fungal infections, sexually transmitted diseases, urinary tract infections, and human papillomaviridae (HPV) infections. Changes in the vaginal microbiome contribute to the development of precancerous cervical lesions. Objective: To evaluate studies associating the vaginal microbiota with HPV, including the risk and persistence of infection and evolution to squamous intraepithelial lesions of the cervix. Methods: A systematic review was conducted based on articles published between September 2011 and September 2019, using the following keyword combinations: "HPV [All Fields] AND "microbiota" [MeSH Terms] OR "microbiota" [All Fields] OR "microbiome" [All Fields])." The keyword search was performed in the MEDLINE, Latin American, and Caribbean Literature in Health Sciences (Lilacs), Cochrane Library, Highwire Stanford, and Embase databases. Results: In total, 239 original articles published between 2011 and 2019 were found in the researched databases on microbiome/microbiota and HPV. After exclusion, only six articles remained. Conclusion: There is a relationship between HPV and the cervicovaginal microbiota, but the mechanism of this influence cannot be specified.


Introdução: O corpo humano é colonizado por trilhões de células microbianas, denominadas microbiota. Microbioma é definida como células microbianas e seus genomas. A microbiota vaginal, especialmente as bactérias produtoras de ácido lático (principalmente Lactobacillus sp.), parece desempenhar um papel crítico na prevenção de várias doenças urogenitais, como a vaginose bacteriana, infecções fúngicas, doenças sexualmente transmissíveis, infecções do trato urinário e infecção pelo Papilomavírus humano (HPV). As alterações no microbioma vaginal parecem contribuir para o desenvolvimento de lesões cervicais pré-cancerosas. Objetivo: Avaliar estudos que associem a microbiota vaginal ao risco de infecção por HPV, sua persistência e evolução para lesões escamosas intraepiteliais do colo do útero. Métodos: Esta é uma revisão sistemática desenvolvida com base em artigos publicados entre setembro de 2011 e setembro de 2019, usando as seguintes combinações de palavras-chave: "HPV" [Todos os Campos] AND ("microbiota" [Termos MeSH] OU "microbiota" [Todos os Campos] OU "microbioma" [All Fields]) nas bases de dados MEDLINE, Latin American and Caribean Health Sciences Literature (Lilacs), Cochrane Library, Highwire Stanford e Embase. Resultados: Entre 2011 e 2019, foram encontrados 239 artigos originais nas bases de dados pesquisadas sobre microbioma/microbiota e HPV. Desse total, após o uso dos critérios de exclusão, restaram apenas seis artigos. Conclusão: Existe uma relação entre o HPV e a microbiota cervicovaginal, mas não foi possível especificar qual mecanismo está envolvido.


Subject(s)
Humans , Female , Vagina/microbiology , Papillomavirus Infections/pathology , Microbiota , Vagina/pathology , Vagina/virology , Sexually Transmitted Diseases/pathology , Risk Factors
2.
Braz. j. infect. dis ; 23(1): 27-33, Jan.-Feb. 2019. tab, graf
Article in English | LILACS | ID: biblio-1001503

ABSTRACT

ABSTRACT Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1) is sexually transmitted and causes persistent infection. This virus induces activation of the immune system and production of inflammatory cytokines. This study aimed to assess the cytokine profile and cytopathological findings in the cervicovaginal fluid of asymptomatic HTLV-1-infected women. Methods: HTLV-1-infected and uninfected women were selected at the Centro de Atendimento ao Portador de HTLV in Salvador-Brazil. None of the included HTLV-1-infected women reported any HTLV-1-associated diseases. All volunteers underwent gynecological examination to collect cervicovaginal fluid. Cytokine quantification was performed using the Cytometric Bead Array (CBA) Human Th1/Th2/Th17 kit. Light microscopy was used to evaluate cervicovaginal cytopathology. In addition, proviral load in cervicovaginal fluid and peripheral blood was measured by real-time quantitative polymerase chain reaction. Results: 112 women (63 HTLV-1-infected and 49 uninfected) were evaluated. No differences were found with respect to cytopathological cervicovaginal findings between the groups. IL-2, TNF, IL-4, IL-10, and IL-17 levels were significantly higher in cervicovaginal fluid of the HTLV-1-infected women than in uninfected women (p < 0.05). Conversely, IFN-γ was found to be lower in the HTLV-1-infected women (p < 0.001) compared to uninfected individuals. Cervicovaginal proviral load was detectable in 53% of the HTLV-1-infected women and was found to be consistently lower than the proviral load in peripheral blood. Conclusions: HTLV-1 infection induces immune activation in cervicovaginal environment, characterized by elevated concentrations of Th1, Th2, and IL17 in the cervicovaginal fluid.


Subject(s)
Humans , Female , Adult , Vagina/pathology , Body Fluids/chemistry , HTLV-I Infections/pathology , Cervix Uteri/pathology , Cytokines/analysis , Social Class , Vagina/immunology , Vagina/virology , Body Fluids/immunology , Enzyme-Linked Immunosorbent Assay , Leukocytes, Mononuclear/virology , Human T-lymphotropic virus 1/isolation & purification , HTLV-I Infections/immunology , HTLV-I Infections/virology , Cervix Uteri/immunology , Cervix Uteri/virology , Cross-Sectional Studies , Th2 Cells/immunology , Th1 Cells/immunology , Statistics, Nonparametric , Viral Load , Interleukin-17/immunology
3.
Femina ; 46(5): 284-294, 20181031. ilus
Article in Portuguese | LILACS | ID: biblio-1050133

ABSTRACT

A atrofia vulvo-vaginal (VVA) é uma condição progressiva e crônica que se manifesta como involução das mucosas vulvo-vaginais e tecidosdevido à diminuição dos níveis de estrogênio. O uso do laser com papel terapêutico ganhou interesse como um tratamento não hormonal para a VVA. Esse estudo objetivou avaliar os efeitos dos lasers de CO2 e Erbium: YAG na flacideze atrofia vulvo-vaginal em mulheres menopausadas. Trata-se de uma revisão integrativa, realizada na base de dados PubMed, utilizando os descritores: vagina, postmenopause, vulvovaginal atrophy, vulvovaginal laxity e laser. Ambos os tipos de lasers aumentam a espessura do epitélio pavimentoso estratificado, estimulam a produção de fibras colágenas, elásticas e outros componentes da matriz extracelular, melhoram a irrigação vascular da vagina e aliviam os sintomas de secura, ardor e dispareunia. No entanto, a duração dos efeitos terapêuticos e a segurança de aplicações repetidas ainda precisam ser mais bem estudados.(AU)


Vulvo-vaginal atrophy (VVA) is a progressive and chronic condition that manifests as involution of the vulvovaginal mucosa and tissues due to decreased levels of estrogen. The use of laser with therapeutic paper gained interest as a non-hormonal treatment for VVA. This study aimed to evaluate the effects of CO2 and Erbium: YAG lasers on vulvovaginal laxity and atrophy in menopausal women. It is an integrative review, carried out in the PubMed database, using the descriptors: vagina, postmenopause, vulvovaginal atrophy, vulvovaginal laxity and laser. Both types of lasers increase the thickness of the stratified squamous epithelium, stimulate the production of collagen, elastic fibers, and other components of the extracellular matrix, improve vascular irrigation of the vagina, and relieve symptoms of dryness, burning, and dyspareunia. However, the duration of therapeutic effects and the safety of repeated applications still need to be better studied.(AU)


Subject(s)
Humans , Female , Middle Aged , Atrophy/surgery , Atrophy/pathology , Vagina/pathology , Vaginal Diseases/surgery , Vulva/pathology , Laser Therapy/methods , United States Food and Drug Administration , Menopause , Collagen , PubMed , Dyspareunia , Erbium/therapeutic use , Estrogens , Lasers, Gas/therapeutic use , Patient Safety
5.
Rev. Assoc. Med. Bras. (1992) ; 63(9): 747-752, 2017. tab, graf
Article in English | LILACS | ID: biblio-896399

ABSTRACT

Summary Introduction: A link of psoriasis with subclinical atherosclerosis has been postulated and cytokine network might intermediate this association. Few data are available in patients with mild psoriasis. We evaluated carotid intima-media thickness (cIMT) in drug-free psoriatic individuals and controls. In parallel, we searched for associations of cIMT with disease activity indexes and serum interleukins (IL) in psoriatic patients. Method: An experienced radiologist performed the cIMT analyses. Cytokine concentrations were assessed by flow cytometry. Disease activity was evaluated based on psoriasis area and severity index (PASI) as well as body surface area (BSA). Results: Sixty-five (65) patients and 64 controls were studied. Mean age of patients (50.9 years) did not differ from controls (p=0.362). A low PASI and BSA (< 10) prevailed (69.2% and 56.9%, respectively). Median levels of IL-12p70, TNF-α, IL-1β and IL-10 were significantly lower in cases than in controls (adjusted p<0.05), while IL-6 and IL-8 medians did not differ between groups (adjusted p>0.05). Smoking habit and diabetes mellitus predominated in cases (p=0.002). An altered cIMT (≥ 0.9 mm) was more frequent in cases than in controls (23.8% versus 8.5%, adjusted p=0.045). Mean cIMT was higher in cases with a borderline significance (p=0.057). cIMT scores did not correlate to PASI (rs=0.066; p=0.250) or BSA (rs=0.175; p=0.185), but did correlate significantly with serum IL-6 (rs=0.26; p=0.005). Conclusion: Subclinical atherosclerosis was more frequent in patients with mild psoriasis than controls. cIMT in psoriatic individuals correlated with serum IL-6, pointing to an eventual proatherogenic role of IL-6 in these patients. Newer studies should clarify the connection of atherogenesis with cytokines in psoriasis.


Resumo Introdução: Foi postulada uma ligação entre psoríase e aterosclerose subclínica. A rede de citocinas pode intermediar essa associação. Poucos dados estão disponíveis em pacientes com psoríase leve. Avaliamos a espessura íntima-média carotídea (cIMT) em psoriáticos e controles livres de medicação. Paralelamente, pesquisamos a associação de cIMT com os índices de atividade de doença e interleucinas séricas (IL) em pacientes com psoríase. Método: Um radiologista experiente procedeu à análise do cIMT. As concentrações de citocinas foram avaliadas por citometria de fluxo. A atividade da doença foi avaliada pelo índice de gravidade (PASI) e pela área de superfície corporal (BSA). Resultados: Sessenta e cinco (65) pacientes e 64 controles foram estudados. A idade média dos pacientes (50,9 anos) não diferiu dos controles (p=0,362). PASI e BSA baixos (< 10) prevaleceram (69,2% e 56,9%, respectivamente). As medianas de IL-12p70, TNF-α, IL-1β e IL-10 foram significativamente menores nos casos do que nos controles (p<0,05 ajustado), enquanto as medianas de IL-6 e IL-8 não diferiram nos grupos (p>0,05 ajustado). Tabagismo e diabetes mellitus predominaram nos casos (p=0,002). Um cIMT alterado (≥ 0,9 mm) foi mais frequente nos casos do que nos controles (23,8% versus 8,5%, p=0,045 ajustado). A média de cIMT foi maior nos casos com significância borderline (p=0,057). Os escores de cIMT não se correlacionaram com o PASI (rs=0,066; p=0,250) ou o BSA (rs=0,175; p=0,185), mas se correlacionaram significativamente com a IL-6 sérica (rs=0,26; p=0,005). Conclusão: A aterosclerose subclínica foi mais frequente em pacientes com psoríase leve do que nos controles. Em psoriáticos, cIMT correlacionou-se com níveis de IL-6 no soro, apontando para um eventual papel pró-aterogênico para a IL-6 nesses pacientes. Novos estudos devem esclarecer a ligação da aterogênese com citocinas na psoríase.


Subject(s)
Humans , Female , Vagina/drug effects , Vaginal Diseases/drug therapy , Plant Extracts/administration & dosage , Isoflavones/administration & dosage , Atrophy/drug therapy , Vagina/pathology , Phytotherapy
6.
Int. braz. j. urol ; 43(4): 746-752, July-Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-892861

ABSTRACT

ABSTRACT Purpose The polypropylene mesh (PPM) is used in many surgical interventions because of its good incorporation and accessibility. However, potential mesh-related complications are common. Platelet-rich plasma (PRP) improves the healing of wounds and is inexpensive. Thus, the purpose of this study was to analyze the effect of the PRP-gel coating of a PPM on inflammation, production of collagen, and smooth muscle in the rabbit vagina. Materials and Methods The intervention consisted of a 1.5cm incision and divulsion of the vaginal mucosa for the implantation of a PRP-coated PPM. The PRP-coated mesh was implanted in 15 rabbits, and in the second group, the same implant was used without the PRP coating. In the sham group, the intervention consisted of the incision, divulsion, and suture. The rabbits were euthanized at 7, 30 and 90 days, and full-thickness sagittal sections of the posterior vaginal wall and rectum were scored. The inflammatory infiltrate was evaluated using hematoxylin and eosin staining. The Sirius Red stain was used to examine deposition of collagen I and III, and Masson's trichrome staining was used to visualize the smooth muscle. Results The group with PRP-coated meshes had a lower inflammatory infiltrate count at 30 days. Deposition of collagen III increased with the use of PRP-coating at 90 days. Conclusions The area of inflammatory infiltrate was significantly increased in the group without the PRP-coated mesh at 30 days but not in the group with the PRP-coated mesh, indicating a less intense inflammatory response. In addition, a significant increase in collagen III occurred at 90 days.


Subject(s)
Animals , Female , Polypropylenes , Surgical Mesh/adverse effects , Vagina/surgery , Platelet-Rich Plasma , Postoperative Complications , Rabbits , Vagina/pathology , Wound Healing , Collagen/metabolism
7.
Reprod. clim ; 32(1): 43-47, 2017.
Article in Portuguese | LILACS | ID: biblio-882559

ABSTRACT

Sintomas relacionados com a atrofia vulvovaginal apresentam um impacto negativo sobre a qualidade de vida de até 50% das mulheres na pós­menopausa. No entanto, algumas recusam o uso de estrogênios, que é a terapia eficaz padrão, devido à publicidade negativa nos últimos anos e à disponibilidade de outras terapias opcionais. Esta revisão avaliou a eficácia de tratamentos hormonais, fitoterápicos de uso oral ou tópico para aliviar os sintomas da atrofia vaginal em mulheres na pós­menopausa. Foram avaliados estudos do Medline, Scopus e Cochrane Central Register de Ensaios Controlados com as palavras­chaves vagina, postmenopause, isoflavones, estrogen, syndrome genitourinária, vulvovaginal atrophy, clinical applications. Estudos de revisão e ensaios clínicos randomizados foram incluídos neste estudo. Os dados mostraram que os estrogênios de uso sistêmico ou local são os mais indicados, as isoflavonas só mostraram efeitos positivos quando de uso local. Alguns tratamentos não hormonais, como hidratantes, lubrificantes e o uso de laser vaginal, também são indicados. Outra possibilidade de tratamento é o ospemifeno, um modulador de receptor hormonal seletivo (SERM) na dispareunia e na atrofia vulvovaginal. Assim, o uso de opções é benéfico para mulheres com risco de neoplasia relacionada aos estrogênios.(AU)


Symptoms related to atrophy vulvovaginal have a negative impact on quality of life up to 50% of women after menopause. However, some refuse the use of estrogens that is the standard effective therapy due to negative publicity in recent years and other available alternatives therapies. This review assessed the effectiveness of hormonal treatments, herbal oral or topical use to relieve the symptoms of vaginal atrophy in women after menopause. We evaluated studies of Medline, Scopus, Cochrane Central Register of Controlled Trials using vagina, postmenopause, isoflavones, estrogen, syndrome genitourinária, vulvovaginal atrophy, clinical applications, as keywords. Review studies and randomized controlled trials were included in this study. The data showed that the systemic or local use of estrogens are the most appropriate, and the isoflavones only showed positive effects when used locally. Some non­hormonal treatments such as moisturizing, lubricating and the use of vaginal laser are also suitable. Another possible treatment is ospemifene, a selective estrogen receptor modulator (SERM) on dyspareunia and vulvovaginal atrophy. Thus, the use of alternatives is beneficial for women with cancer risk related to estrogens.(AU)


Subject(s)
Humans , Female , Atrophy , Estrogens/therapeutic use , Female Urogenital Diseases/drug therapy , Isoflavones/therapeutic use , Vagina/pathology
8.
Clinics ; 71(5): 291-294, May 2016. tab, graf
Article in English | LILACS | ID: lil-782837

ABSTRACT

OBJECTIVES: To evaluate the effect of Carbopol gel formulations containing pilocarpine on the morphology and morphometry of the vaginal epithelium of castrated rats. METHODS: Thirty-one female Wistar-Hannover rats were randomly divided into four groups: the control Groups I (n=7, rats in persistent estrus; positive controls) and II (n=7, castrated rats, negative controls) and the experimental Groups, III (n=8) and IV (n=9). Persistent estrus (Group I) was achieved with a subcutaneous injection of testosterone propionate on the second postnatal day. At 90 days postnatal, rats in Groups II, III and IV were castrated and treated vaginally for 14 days with Carbopol gel (vehicle alone) or Carbopol gel containing 5% and 15% pilocarpine, respectively. Next, all of the animals were euthanized and their vaginas were removed for histological evaluation. A non-parametric test with a weighted linear regression model was used for data analysis (p<0.05). RESULTS: The morphological evaluation showed maturation of the vaginal epithelium with keratinization in Group I, whereas signs of vaginal atrophy were present in the rats of the other groups. Morphometric examinations showed mean thickness values of the vaginal epithelium of 195.10±12.23 μm, 30.90±1.14 μm, 28.16±2.98 μm and 29.84±2.30 μm in Groups I, II, III and IV, respectively, with statistically significant differences between Group I and the other three groups (p<0.0001) and no differences between Groups II, III and IV (p=0.0809). CONCLUSION: Topical gel formulations containing pilocarpine had no effect on atrophy of the vaginal epithelium in the castrated female rats.


Subject(s)
Animals , Female , Muscarinic Agonists/pharmacology , Pilocarpine/pharmacology , Vagina/pathology , Atrophy/drug therapy , Epithelium/drug effects , Epithelium/pathology , Models, Animal , Random Allocation , Rats, Wistar , Vagina/drug effects
9.
Clinics ; 71(2): 90-93, Feb. 2016. tab, graf
Article in English | LILACS | ID: lil-774531

ABSTRACT

OBJECTIVES: Vaginal atrophy and breast cancer are common conditions in postmenopausal women and tamoxifen is the standard endocrine treatment for hormone-sensitive tumors. The present study aimed to assess the effect of tamoxifen on Ki-67 protein expression in the vaginal epithelium of castrated rats. MATERIAL AND METHODS: Forty Wistar-Hannover adult, virgin, castrated rats were randomly divided into two groups, group I (control, n=20) and group II (tamoxifen, n=20), receiving 0.5 ml of propylene glycol and 250 µg of tamoxifen diluted in 0.5 ml of propylene glycol, respectively, daily by gavage for 30 days. On the 31st day, the rats were euthanized and their vaginas were removed and fixed in 10% buffered formalin for the immunohistochemical study of Ki-67 protein expression. Data were analyzed by the Levene and Student’s t tests (p<0.05). RESULTS: The mean index of Ki-67 expression in the rat vagina of groups I and II was 4.04±0.96 and 26.86±2.19, respectively (p<0.001). CONCLUSIONS: According to the results of the present study, tamoxifen, at the dose and treatment length used, induced a significant increase in the cell proliferation of the vaginal mucosa in castrated rats, as evaluated by Ki-67 protein expression.


Subject(s)
Animals , Female , Cell Proliferation/drug effects , /metabolism , Selective Estrogen Receptor Modulators/pharmacology , Tamoxifen/pharmacology , Vagina/metabolism , Epithelium/drug effects , Epithelium/metabolism , Epithelium/pathology , Models, Animal , Random Allocation , Rats, Wistar , Vagina/drug effects , Vagina/pathology
10.
Rev. chil. obstet. ginecol ; 81(5): 388-392, 2016. ilus
Article in Spanish | LILACS | ID: biblio-830149

ABSTRACT

La dehiscencia de la cúpula vaginal, con o sin evisceración, es una complicación rara de la cirugía ginecológica. El principal factor de riesgo es el antecedente de una histerectomía, a lo que se añaden otros factores desencadenantes, entre los que destaca la atrofia vaginal. El diagnóstico de evisceración es fácil, al comprobar salida de material intestinal a través de la vagina, siendo más dificultoso el diagnóstico de dehiscencia, ya que puede acontecer con síntomas banales. El tratamiento supone una urgencia quirúrgica al existir riesgo de lesión intestinal y peritonitis, pudiéndose realizar diferentes vías de abordaje teniendo en cuenta sobre todo la clínica de la paciente y tras comprobar el estado del contenido eviscerado. Presentamos el caso de una paciente con varios factores de riesgo, que presentó dehiscencia de la cúpula vaginal con evisceración de intestino de manera reiterada, y a la que se le practicó tratamiento quirúrgico por diferentes vías de abordaje así como tratamiento médico.


Dehiscence of the vaginal vault with or without evisceration is a rare complication after gynaecological surgery. The main risk factor is a previous hysterectomy, with the addition of other trigger conditions, the most important is vaginal atrophy. The diagnosis of evisceration is easy by confirmation the loosing of intestinal contents through the vagina. Diagnosis of dehiscence is more difficult because its symptoms could be more generic. The treatment is an emergency surgery as there is a risk of intestinal injury and peritonitis. There could be different surgical approaches taking into consideration the patient's clinic symptoms and after checking the state of eviscerated tissues. We expose the case of a patient with several risk factors, who presented dehiscence of the vaginal vault with recurrent bowel evisceration, and who we performed surgical treatment by different approaches and medical treatment.


Subject(s)
Humans , Female , Aged , Hysterectomy/adverse effects , Surgical Wound Dehiscence/etiology , Vagina/surgery , Recurrence , Uterine Prolapse/etiology , Vagina/pathology
11.
Journal of Gynecologic Oncology ; : e18-2016.
Article in English | WPRIM | ID: wpr-100614

ABSTRACT

OBJECTIVE: Uterine carcinosarcoma (UCS) shared the same staging system with endometrial carcinoma in the International Federation of Gynecology and Obstetrics 2009. The aim of the present study was to compare the clinicopathological and prognostic characteristics between UCS and grade 3 endometrioid endometrial carcinoma (G3EC). METHODS: A retrospective analysis of 60 UCS and 115 G3EC patients with initial treatment at the Department of Gynecology in the Fudan University Shanghai Cancer Center between February 2006 and August 2013. Chi-square analysis was used to compare differences between variables. Prognostic factors were determined using univariate/multivariate analysis, and the survival rates were assessed using the Kaplan-Meier method. The Cox regression model was used to assess the independent prognostic factor. RESULTS: UCS had significantly worse overall survival (OS) compared with G3EC. Carcinosarcoma subtype was an independent factor (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.0 to 5.8; p=0.039), stratified based on stage. Compared with G3EC, UCS patients had a greater incidence of ascites fluid (55.0% vs. 15.7%, p<0.001) and adnexal involvement (20.0% vs. 8.7%, p=0.048) and larger median tumor volume (4.6 cm vs. 4.0 cm, p=0.046). Subgroup analysis of the prognostic factors revealed that UCS patients exhibited worse OS than G3EC patients in such specific subgroups as patients at younger ages, with postmenopausal status, without ascites fluid, with early stage diseases, without vagina invasion, without lymph node metastases and receiving adjuvant chemo/radiotherapy. Adjuvant radiotherapy with chemotherapy was predictive of better survival in UCS patients compared with chemotherapy or radiotherapy alone (5-year OS, 71.0% vs. 35.8%, p=0.028). Multivariate Cox regression revealed that tumor mesenchymal component (HR, 4.6; 95% CI, 1.4 to 15.8; p=0.014) was an independent prognostic factor for UCS, whereas advanced stages (HR, 5.9; 95% CI, 1.0 to 33.9; p=0.046) and ascites fluid (HR, 5.1; 95% CI, 1.1 to 22.7; p=0.032) were independently correlated with poor prognosis for G3EC patients. CONCLUSION: The distinctions in both clinicopathological and prognostic characteristics between UCS and G3EC suggest that this subtype should be treated separately from high-risk epithelial endometrial carcinoma.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged , Adnexa Uteri/pathology , Age Factors , Aorta , Ascites/etiology , Carcinoma, Endometrioid/secondary , Carcinosarcoma/secondary , Chemotherapy, Adjuvant , Cytoreduction Surgical Procedures , Endometrial Neoplasms/pathology , Hysterectomy , Lymph Node Excision , Lymphatic Metastasis , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Staging , Pelvis , Postmenopause , Radiotherapy, Adjuvant , Retrospective Studies , Survival Rate , Tumor Burden , Vagina/pathology
12.
Article in English | IMSEAR | ID: sea-157093

ABSTRACT

Background & objectives: Gonorrhoea is among the most frequent of the estimated bacterial sexually transmitted infections (STIs) and has significant health implications in women. The use of nucleic acid amplification tests (NAATs) has been shown to provide enhanced diagnosis of gonorrhoea in female patients. However, it is recommended that an on-going assessment of the test assays should be performed to check for any probable sequence variation occurring in the targeted region. In this study, an in-house PCR targeting opa-gene of Neisseria gonorrhoeae was used in conjunction with 16S ribosomal PCR to determine the presence of gonorrhoea in female patients attending the tertiary care hospitals. Methods: Endocervical samples collected from 250 female patients with complaints of vaginal or cervical discharge or pain in lower abdomen were tested using opa and 16S ribosomal assay. The samples were also processed by conventional methods. Results: Of the 250 female patients included in the study, only one was positive by conventional methods (microscopy and culture) whereas 17 patients were found to be positive based on PCR results. Interpretation & conclusions: The clinical sensitivity of conventional methods for the detection of N. gonorrhoeae in female patients was low. The gonococcal detection rates increased when molecular method was used giving 16 additional positives. Studies should be done to find out other gene targets that may be used in the screening assays to detect the presence of gonorrhoea.


Subject(s)
Bacterial Outer Membrane Proteins , Female , Gonorrhea/diagnosis , Gonorrhea/genetics , Gonorrhea/microbiology , Humans , India , Neisseria gonorrhoeae/genetics , Neisseria gonorrhoeae/isolation & purification , Nucleic Acid Amplification Techniques , RNA, Ribosomal, 16S/genetics , Tertiary Care Centers , Vagina/microbiology , Vagina/pathology
13.
Rev. bras. ginecol. obstet ; 36(8): 347-352, 08/2014. tab
Article in Portuguese | LILACS | ID: lil-720500

ABSTRACT

OBJETIVO: Avaliar a acurácia da citologia cervicovaginal realizada no principal laboratório do Estado de Roraima, por concordância entre avaliadores (monitoramento externo) e com resultados histopatológicos. MÉTODOS: Lâminas de 100 mulheres, de uma amostra de conveniência de base populacional, foram avaliadas pelo LAPER, principal laboratório de referência do Sistema Único de Saúde do Estado de Roraima e reavaliadas por médicos patologistas experts externos ao laboratório. Foram avaliados índice Kappa, sensibilidade e especificidade. O estudo foi aprovado pela Coordenação do Laboratório Estadual e pelo Comitê de Ética em Pesquisa da Universidade Federal de Roraima. RESULTADOS: Quanto à prevalência de atipias celulares (relacionadas ao papilomavírus humano), não houve concordância entre resultados emitidos pelo LAPER e pelos patologistas externos (k=0,21). Constatou-se baixa sensibilidade (28,5%) e especificidade de 89,2% para o desempenho do LAPER, com elevada proporção de resultados falsos positivos e falsos negativos. Os laudos citológicos de patologistas externos apresentaram sensibilidade e especificidade maiores (71,4 e 98,9%, respectivamente), descartando que erros de coleta e coloração possam explicar o baixo desempenho do LAPER. CONCLUSÃO: O baixo desempenho diagnóstico da citologia cervicovaginal pode ser uma barreira para o controle do câncer de colo de útero em Roraima. Ressalta-se a necessidade de capacitação profissional e monitoramento interno e externo em Estados brasileiros com alta incidência de câncer de colo de útero. .


PURPOSE: To evaluate the validity of cervicovaginal cytology performed at LAPER, the main Laboratory of Pathology of the State of Roraima, Brazil, by interrater agreement (external monitoring) and agreement with histopathologic results. METHODS: One hundred women were included, a population-based convenience sample. Their cervical cytological exams were evaluated by the laboratory staff and reviewed by expert medical pathologists, external to the laboratory. Cohen's Kappa index, sensitivity and specificity were evaluated. The study was approved by LAPER coordination and Federal University of Roraima Research Ethics Commitee. RESULTS: Regarding the prevalence of human papillomavirus-related atypical, there was no concordance between the results issued by LAPER and by the external pathologists (k=0.21). A low sensitivity (28.5%) and specificity (89,2%) was detected for the diagnostic performance of LAPER, with a high proportion of false positive and false negative results. The cytological reports of the external pathologists showed higher sensitivity and specificity (71.4 and 98.9%, respectively), ruling out the possibility that errors related to collection methods and staining would explain the low performance of the laboratory. CONCLUSION: A low diagnostic accuracy of cervicovaginal cytology can be a barrier against the control of cervical cancer in Roraima. We emphasize the need for professional training and internal and external monitoring in Brazilian states with a high incidence of cervical cancer. .


Subject(s)
Female , Humans , Cervix Uteri/pathology , Uterine Cervical Neoplasms/pathology , Vaginal Smears , Vagina/pathology , Brazil/epidemiology , Incidence , Reproducibility of Results , Sensitivity and Specificity , Uterine Cervical Neoplasms/epidemiology
14.
Einstein (Säo Paulo) ; 10(4): 466-472, Oct.-Dec. 2012. ilus, tab
Article in English | LILACS | ID: lil-662473

ABSTRACT

OBJECTIVE: To compare two oncotic cervical cytology techniques, the conventional and the liquid-based cytology, in low risk patients for uterine cervical cancer. METHODS: Comparative prospective study with 100 patients who came to their annual gynecological exam, and were submitted simultaneously to both techniques. We used the McNemar test, with a significance level of p<0.05 to compare the results obtained related to adequacy of the smear quality, descriptive diagnosis prevalence, guided biopsy confirmation and histology. RESULTS: Adequacy of the smear was similar for both methods. The quality with squamocolumnar junction in 93% of conventional cytology and in 84% of the liquid-based cytology had statistical significance. As for the diagnosis of atypical cells they were detected in 3% of conventional cytology and in 10% of liquidbased cytology (p=0.06). Atypical squamous cells of undetermined significance were the most prevalent abnormality. The liquid-based cytology performance was better when compared with colposcopy (guided biopsy), presenting sensitivity of 66.7% and specificity of 100%. There was no cytological and histological concordance for the conventional cytology. CONCLUSIONS: Liquid-based cytology had a better performance to diagnose atypical cells and the cytohistological concordance was higher than in the conventional cytology.


OBJETIVO: Comparar duas técnicas de colpocitologia oncótica, a convencional e a em meio líquido, em pacientes de baixo risco para carcinoma de colo uterino. MÉTODOS: Trata-se de estudo prospectivo e comparativo, em que foram avaliadas cem mulheres que compareceram à consulta médica de rotina e foram submetidas simultaneamente à coleta pelas duas técnicas de citologia. Os resultados obtidos em relação à adequabilidade, à qualidade dos esfregaços, à prevalência nos diagnósticos descritivos e à confirmação com biópsia dirigida e histologia foram comparados pelo teste de McNemar, com nível de significância de p<0,05. RESULTADOS: A adequabilidade dos esfregaços mostrou-se semelhante. A qualidade, com presença de elementos da junção escamo-colunar em 93% das citologias convencionais e 84% das citologias em meio líquido, teve significância estatística. Nos diagnósticos de atipias, elas foram detectadas em 3% das citologias convencionais e em 10% das citologias em meio líquido (p=0,06), sendo as atipias em células escamosas de significado indeterminado a alteração mais prevalente. Quando comparadas à colposcopia com biópsia dirigida, o desempenho da citologia em meio líquido foi superior, com sensibilidade de 66,7% e especificidade de 100%, enquanto que, para a citologia convencional, não houve concordância cito-histológica. CONCLUSÃO: O desempenho em diagnosticar atipias e a concordância cito-histológica da citologia em meio líquido foram superiores ao da citologia convencional.


Subject(s)
Female , Humans , Cervix Uteri/pathology , Colposcopy/methods , Uterine Cervical Neoplasms/pathology , Vagina/pathology , Vaginal Neoplasms/pathology , Vaginal Smears/methods , Prospective Studies , Sensitivity and Specificity
15.
Femina ; 40(6): 331-338, Nov.-Dez. 2012. tab
Article in Portuguese | LILACS | ID: lil-708375

ABSTRACT

Apesar dos avanços na área da Obstetrícia, a prematuridade ainda é a principal causa de morbidade e mortalidade neonatal. Esforços continuam sendo feitos na busca de marcadores que possam predizer tal evento e, assim, evitar o parto prematuro. A presente revisão abordou a relação da infecção genital com a prematuridade e sua influência nos resultados dos principais indicadores preditivos do parto prematuro, bem como a eficácia da antibioticoterapia. Os estudos revisados sugerem que o tratamento da vaginose bacteriana relaciona-se a resultados satisfatórios para a prevenção da prematuridade somente se realizado na primeira metade da gestação. A alteração dos testes preditivos não indica, por si só, o uso de antibióticos.


Despite advances in the field of Obstetrics, prematurity is still responsible for the leading cause of neonatal morbidity and mortality. Efforts are still being made in the search for markers that can predict such an event and thus prevent premature delivery. This review explores the relationship of genital infection with preterm birth and its influence on the results of the main preterm birth predictive markers, as well as the effectiveness of antibiotics. The revised studies suggest that treatment of bacterial vaginosis relates to satisfactory results for the prevention of preterm performed only if the first half of pregnancy. The change of predictive tests not indicates, by itself, the use of antibiotics.


Subject(s)
Humans , Female , Pregnancy , Biomarkers/analysis , Obstetric Labor, Premature/diagnosis , Obstetric Labor, Premature/prevention & control , Vagina/pathology , Cervix Uteri , Pregnancy Complications, Infectious/microbiology , Fibronectins/analysis , Insulin-Like Growth Factor I , Cervical Length Measurement/methods , Premature Birth/prevention & control , Predictive Value of Tests , Reproductive Tract Infections , Vaginosis, Bacterial/drug therapy
16.
Indian J Pathol Microbiol ; 2011 Jul-Sept 54(3): 572-573
Article in English | IMSEAR | ID: sea-142046

ABSTRACT

We report a case of a 47-year-old female (posthysterectomy) with bleeding per vaginam. Imaging studies showed a large abdomino-pelvic mass diagnosed as extrauterine adenomyoma with uterus-like features. This pathological entity is extremely uncommon with only few case reports available in the reported literature. This case is being highlighted for its rarity and to discuss the possible theories for origin of this uncommon condition.


Subject(s)
Adenomyoma/diagnosis , Adenomyoma/pathology , Female , Hemorrhage/pathology , Histocytochemistry , Humans , Hysterectomy , Microscopy , Middle Aged , Pelvis/diagnostic imaging , Radiography, Abdominal , Tomography, X-Ray Computed , Uterine Neoplasms/diagnosis , Uterine Neoplasms/pathology , Uterus/pathology , Vagina/pathology
17.
J. venom. anim. toxins incl. trop. dis ; 17(4): 460-466, 2011. tab
Article in English | LILACS | ID: lil-623509

ABSTRACT

In order to evaluate the pathogenicity of yeasts isolated from vaginal secretion of pregnant and non-pregnant women - stored in mineral oil at the URM Mycology Collection, Department of Mycology, Federal University of Pernambuco - 30 samples belonging to the genera Candida, Rhodotorula, Trichosporon, and Kloeckera, were studied regarding their pathogenic characteristics, ability to grow at room temperature (28°C ± 1°C), 37°C, and 42°C for 72 hours, and production of both phospholipase and proteinase. Results showed that all 30 isolates (100%) were able to grow at room temperature and 37°C, and that 17 samples (57%) were able to grow at 42°C. Evaluation of enzymatic activity showed protease activity in only two isolates (7%), namely C. maritima and C. obtusa. Phospholipase activity was detected in 20 isolates (67%) using soy lecithin as substrate at different temperatures. The characterization of yeasts isolated from vaginal secretion and determination of their enzymatic activity may contribute to understanding the epidemiology of vulvovaginitis and assist in the treatment of patients.


Subject(s)
Humans , Female , Adult , Enzymes , Mineral Oil , Mucous Membrane/microbiology , Mucous Membrane/pathology , Vagina/microbiology , Vagina/pathology
18.
Femina ; 38(7)jul. 2010. tab
Article in Portuguese | LILACS | ID: lil-562401

ABSTRACT

Os sintomas decorrentes da atrofia vulvovaginal são muito comuns no climatério. Os estrogênios aplicados localmente na vagina se mostram eficazes no alívio de tais manifestações; no entanto, os estrogênios conjugados na forma de creme vaginal apresentam efeitos sistêmicos e o estriol aplicado localmente pode ser absorvido sistemicamente também. O promestrieno é um estrogênio cuja absorção sistêmica é desprezível quando empregado topicamente, porém a falta de revisão sistemática sobre o tema suscitou a realização da presente revisão. Foram incluídos 16 estudos publicados entre 1976 e 2009, que avaliaram eficácia do promestrieno no alívio dos sintomas decorrentes da atrofia vulvovaginal, ou que investigaram seus efeitos na citologia vaginal, e também aqueles que avaliaram a absorção da substância quando empregada topicamente. As evidências encontradas confirmaram a eficácia do promestrieno, utilizado localmente no tratamento das afecções atróficas genitais femininas decorrentes do hipoestrogenismo, aliada a absorção sistêmica desprezível


The symptoms resulting from vulvovaginal atrophy are very common during climacteric. Estrogens applied locally in the vagina are effective in relieving these manifestations, however, conjugated estrogens as vaginal cream have systemic effects and locally applied estriol may be systemically absorbed. Promestriene is an estrogen without systemic absorption when applied topically, but the lack of a systematic review on the substance motivated the idea to make this review. Sixteen studies published between 1976 and 2009 which evaluated the effectiveness of promestriene on the relief of symptoms resulting from vulvovaginal atrophy or which investigated its effects on vaginal cytology and those which evaluated the absorption of the substance when used locally were included. The found evidences confirmed the effectiveness of locally applied promestriene in the treatment of female genital atrophic disorders due to low estrogen levels coupled with negligible systemic absorption


Subject(s)
Humans , Female , Middle Aged , Administration, Intravaginal , Atrophy/drug therapy , Estradiol/administration & dosage , Estradiol/analogs & derivatives , Estrogens/deficiency , Postmenopause , Estrogen Replacement Therapy/methods , Vagina/pathology , Vulva/pathology , Female Urogenital Diseases/drug therapy
19.
Rev. chil. endocrinol. diabetes ; 3(3): 208-210, jul. 2010.
Article in Spanish | LILACS | ID: lil-610321

ABSTRACT

Urogenital atrophy is characterized by dryness, inflammation, and thinning of the epithelial lining of the vagina and lower urinary tract due to estrogen decline. Local estrogen therapy if effective to relieve signs and symptoms of vaginal atrophy without causing an elevation of serum estrogen levels. Although there are no big studies addressing the safety of this type of treatment, it can be maintained over long periods to avoid annoying symptoms. Special care must be taken with women with breast cancer in whom the effective dose must be titrated to avoid an increase in serum estrogens over the levels usually observed in postmenopausal women.


Subject(s)
Humans , Female , Female Urogenital Diseases/drug therapy , Estradiol/administration & dosage , Estriol/administration & dosage , Estrogens/administration & dosage , Administration, Intravaginal , Atrophy/drug therapy , Breast Neoplasms , Climacteric , Ointments , Tablets , Vaginal Creams, Foams, and Jellies , Vagina , Vagina/pathology
20.
Pakistan Journal of Medical Sciences. 2010; 26 (2): 470-473
in English | IMEMR | ID: emr-98003

ABSTRACT

Vaginal foreign bodies in girls may be accidental, self-inflicted or secondary to child abuse. These may causes a number of complications like Infections, abscess formation, intestinal perforation, vaginal discharge and internal fistulae. We are presenting a case of a 13 years old girl who presented with a supra-pubic mass and dysuria. X-ray showed a radio-opaque shadow in pelvis. The child was admitted in medical ward with the diagnosis of bladder stone and UTI. She was pouring frank pus from the vagina. On rectal digital examination a hard foreign body was felt in the rectum. Investigations revealed that she had a large pelvic collection, a sharp wooden Foreign Body [FB] extending from the rectum through the vagina in to the urinary bladder forming a bladder stone. Patient also developed recto-vaginal and vesico-vaginal fistulae. Foreign body was removed along with the bladder stone, pelvic abscess drained and colostomy was performed. Later repair of vesico-vaginal fistula were performed, recto-vaginal fistula closed spontaneously and colostomy closed. Patient became fully continent for urine and feces after completion of surgical procedures. A careful history from the child revealed that she had inserted the foreign body herself as a self-exploring practice


Subject(s)
Humans , Female , Child , Foreign Bodies/complications , Vagina/pathology , Urinary Bladder Calculi
SELECTION OF CITATIONS
SEARCH DETAIL